Top

Published in:

01-01-2016 | Review Article

Cargo trafficking in Alzheimer’s disease: the possible role of retromer

Authors: Saeed Sadigh-Eteghad, Mohammad Sadegh Askari-Nejad, Javad Mahmoudi, Alireza Majdi

Published in: Neurological Sciences | Issue 1/2016

Abstract

Alzheimer’s disease (AD) as one of the ongoing neurological disorders is initiated and progressed by multiple pathological pathways. Cargoes trafficking pathways, such as recycling, play a crucial role in the pathogenesis of AD. One of the major constituents of this trafficking system in neurons is retromer which acts in endosomal sorting machinery. Defective retromer disrupts recycling of cargoes from endosomes to Golgi and leads to its mis-trafficking which may subsequently leads to AD. Also, retromer-related cargo trafficking could trigger amyloidogenic pathway and beta-amyloid production. Wingless is another cargo in Wnt pathways and its trafficking is mediated by retromer. Retromer malfunction leads to lack of Wnt and subsequent AD-related pathogenesis. Also, retromer plays role in synaptic receptor trafficking in physiologic and pathologic conditions. This review is brief survey on the recent published literatures about pathogenesis of retromer-related trafficking in amyloid precursor protein pathways, Wnt signaling, synaptic function, and also revised the structural role of retromer in AD progression.

Sadigh-Eteghad S, Majdi A, Farhoudi M, Talebi M, Mahmoudi J (2014) Different patterns of brain activation in normal aging and Alzheimer’s disease from cognitional sight: meta analysis using activation likelihood estimation. J Neurol Sci 343(1–2):159–166. doi:10.1016/j.jns.2014.05.066 PubMedCrossRef

Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM (2007) Forecasting the global burden of Alzheimer’s disease. Alzheimers Dement 3(3):186–191. doi:10.1016/j.jalz.2007.04.381 PubMedCrossRef

Muhammad A, Flores I, Zhang H, Yu R, Staniszewski A, Planel E, Herman M, Ho L, Kreber R, Honig LS (2008) Retromer deficiency observed in Alzheimer’s disease causes hippocampal dysfunction, neurodegeneration, and Aβ accumulation. Proc Natl Acad Sci 105(20):7327–7332PubMedPubMedCentralCrossRef

Bonifacino JS, Hurley JH (2008) Retromer. Curr Opin Cell Biol 20(4):427–436PubMedPubMedCentralCrossRef

Arighi CN, Hartnell LM, Aguilar RC, Haft CR, Bonifacino JS (2004) Role of the mammalian retromer in sorting of the cation-independent mannose 6-phosphate receptor. J Cell Biol 165(1):123–133PubMedPubMedCentralCrossRef

Sullivan CP, Jay AG, Stack EC, Pakaluk M, Wadlinger E, Fine RE, Wells JM, Morin PJ (2011) Retromer disruption promotes amyloidogenic APP processing. Neurobiol Dis 43(2):338–345PubMedPubMedCentralCrossRef

Sadigh-Eteghad S, Sabermarouf B, Majdi A, Talebi M, Farhoudi M, Mahmoudi J (2015) Amyloid-beta: a crucial factor in Alzheimer’s disease. Med Princ Pract 24(1):1–10. doi:10.1159/000369101 PubMedCrossRef

Jarrett JT, Lansbury PT Jr (1993) Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie? Cell 73(6):1055–1058PubMedCrossRef

Pastorino L, Sun A, Lu P-J, Zhou XZ, Balastik M, Finn G, Wulf G, Lim J, Li S-H, Li X (2006) The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production. Nature 440(7083):528–534PubMedCrossRef

10.

Wilhelmus M, Otte-Höller I, Wesseling P, De Waal R, Boelens W, Verbeek M (2006) Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer’s disease brains. Neuropathol Appl Neurobiol 32(2):119–130PubMedCrossRef

11.

Eaton S (2008) Retromer retrieves wntless. Dev Cell 14(1):4–6PubMedCrossRef

12.

Willert K, Nusse R (2012) Wnt proteins. Cold Spring Harb Perspect Biol 4(9):a007864PubMedPubMedCentralCrossRef

13.

Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, van den Born M, Barker N, Shroyer NF, van de Wetering M, Clevers H (2011) Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 469(7330):415–418PubMedPubMedCentralCrossRef

14.

Cerpa W, Godoy JA, Alfaro I, Farías GG, Metcalfe MJ, Fuentealba R, Bonansco C, Inestrosa NC (2008) Wnt-7a modulates the synaptic vesicle cycle and synaptic transmission in hippocampal neurons. J Biol Chem 283(9):5918–5927PubMedCrossRef

15.

Fjorback AW, Seaman M, Gustafsen C, Mehmedbasic A, Gokool S, Wu C, Militz D, Schmidt V, Madsen P, Nyengaard JR (2012) Retromer binds the FANSHY sorting motif in SorLA to regulate amyloid precursor protein sorting and processing. J Neurosci 32(4):1467–1480PubMedCrossRef

16.

Small SA, Petsko GA (2015) Retromer in Alzheimer disease, Parkinson disease and other neurological disorders. Nat Rev Neurosci 16:126–132PubMedCrossRef

17.

Seaman MN (2005) Recycle your receptors with retromer. Trends Cell Biol 15(2):68–75PubMedCrossRef

18.

Norwood SJ, Shaw DJ, Cowieson NP, Owen DJ, Teasdale RD, Collins BM (2011) Assembly and solution structure of the core retromer protein complex. Traffic 12(1):56–71PubMedCrossRef

19.

Wassmer T, Attar N, Bujny MV, Oakley J, Traer CJ, Cullen PJ (2007) A loss-of-function screen reveals SNX5 and SNX6 as potential components of the mammalian retromer. J Cell Sci 120(1):45–54PubMedCrossRef

20.

Rojas R, Kametaka S, Haft CR, Bonifacino JS (2007) Interchangeable but essential functions of SNX1 and SNX2 in the association of retromer with endosomes and the trafficking of mannose 6-phosphate receptors. Mol Cell Biol 27(3):1112–1124PubMedPubMedCentralCrossRef

21.

Collins BM (2008) The structure and function of the retromer protein complex. Traffic 9(11):1811–1822PubMedCrossRef

22.

Small SA, Gandy S (2006) Sorting through the cell biology of Alzheimer’s disease: intracellular pathways to pathogenesis. Neuron 52(1):15–31PubMedCrossRef

23.

Wen L, Tang F-L, Hong Y, Luo S-W, Wang C-L, He W, Shen C, Jung J-U, Xiong F, D-h Lee (2011) VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology. J Cell Biol 195(5):765–779PubMedPubMedCentralCrossRef

24.

Small SA, Kent K, Pierce A, Leung C, Kang MS, Okada H, Honig L, Vonsattel JP, Kim TW (2005) Model-guided microarray implicates the retromer complex in Alzheimer’s disease. Ann Neurol 58(6):909–919PubMedCrossRef

25.

Munsie L, Milnerwood A, Seibler P, Beccano-Kelly D, Tatarnikov I, Khinda J, Volta M, Kadgien C, Cao L, Tapia L (2015) Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson’s disease VPS35 mutation p. D620N. Hum Mol Genet 24(6):1691–1703PubMedCrossRef

26.

Selkoe DJ (2002) Alzheimer’s disease is a synaptic failure. Science 298(5594):789–791PubMedCrossRef

27.

Seaman MN (2012) The retromer complex—endosomal protein recycling and beyond. J Cell Sci 125(20):4693–4702PubMedPubMedCentralCrossRef

28.

Priller C, Bauer T, Mitteregger G, Krebs B, Kretzschmar HA, Herms J (2006) Synapse formation and function is modulated by the amyloid precursor protein. J Neurosci 26(27):7212–7221PubMedCrossRef

29.

Kang J, Lemaire H-G, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K-H, Multhaup G, Beyreuther K, Müller-Hill B (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325:733–736PubMedCrossRef

30.

Bhalla A, Vetanovetz CP, Morel E, Chamoun Z, Di Paolo G, Small SA (2012) The location and trafficking routes of the neuronal retromer and its role in amyloid precursor protein transport. Neurobiol Dis 47(1):126–134PubMedPubMedCentralCrossRef

31.

Wassmer T, Attar N, Harterink M, van Weering JR, Traer CJ, Oakley J, Goud B, Stephens DJ, Verkade P, Korswagen HC (2009) The retromer coat complex coordinates endosomal sorting and dynein-mediated transport, with carrier recognition by the trans-Golgi network. Dev Cell 17(1):110–122PubMedPubMedCentralCrossRef

32.

Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, Wong PC (2001) BACE1 is the major β-secretase for generation of Aβ peptides by neurons. Nat Neurosci 4(3):233–234PubMedCrossRef

33.

Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D, Ward PJ (1990) Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248(4959):1122–1124PubMedCrossRef

34.

Vetrivel KS, Thinakaran G (2006) Amyloidogenic processing of β-amyloid precursor protein in intracellular compartments. Neurology 66(1 suppl 1):S69–S73PubMedCrossRef

35.

Zheng L, Cedazo-Minguez A, Hallbeck M, Jerhammar F, Marcusson J, Terman A (2012) Intracellular distribution of amyloid beta peptide and its relationship to the lysosomal system. Transl Neurodegener 1(19):10.1186

36.

Thinakaran G, Koo EH (2008) Amyloid precursor protein trafficking, processing, and function. J Biol Chem 283(44):29615–29619PubMedPubMedCentralCrossRef

37.

Choy RW-Y, Cheng Z, Schekman R (2012) Amyloid precursor protein (APP) traffics from the cell surface via endosomes for amyloid β (Aβ) production in the trans-Golgi network. Proc Natl Acad Sci 109(30):E2077–E2082PubMedPubMedCentralCrossRef

38.

Hu X, Crick SL, Bu G, Frieden C, Pappu RV, Lee J-M (2009) Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc Natl Acad Sci 106(48):20324–20329PubMedPubMedCentralCrossRef

39.

Nunan J, Shearman MS, Checler F, Cappai R, Evin G, Beyreuther K, Masters CL, Small DH (2001) The C-terminal fragment of the Alzheimer’s disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from γ-secretase. Eur J Biochem 268(20):5329–5336PubMedCrossRef

40.

Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297(5580):353–356PubMedCrossRef

41.

Okada H, Zhang W, Peterhoff C, Hwang JC, Nixon RA, Ryu SH, Kim T-W (2010) Proteomic identification of sorting nexin 6 as a negative regulator of BACE1-mediated APP processing. FASEB J 24(8):2783–2794PubMedPubMedCentralCrossRef

42.

Wang C-L, Tang F-L, Peng Y, Shen C-Y, Mei L, Xiong W-C (2012) VPS35 regulates developing mouse hippocampal neuronal morphogenesis by promoting retrograde trafficking of BACE1. Biol Open 1(12):1248–1257PubMedPubMedCentralCrossRef

43.

Small SA (2008) Retromer sorting: a pathogenic pathway in late-onset Alzheimer disease. Arch Neurol 65(3):323–328PubMedPubMedCentralCrossRef

44.

Seaman MN (2004) Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer. J Cell Biol 165(1):111–122PubMedPubMedCentralCrossRef

45.

Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, Katayama T, Baldwin CT, Cheng R, Hasegawa H (2007) The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet 39(2):168–177PubMedPubMedCentralCrossRef

46.

Schmidt V, Baum K, Lao A, Rateitschak K, Schmitz Y, Teichmann A, Wiesner B, Petersen CM, Nykjaer A, Wolf J (2012) Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer’s disease. EMBO J 31(1):187–200PubMedPubMedCentralCrossRef

47.

Andersen OM, Reiche J, Schmidt V, Gotthardt M, Spoelgen R, Behlke J, Von Arnim CA, Breiderhoff T, Jansen P, Wu X (2005) Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci USA 102(38):13461–13466PubMedPubMedCentralCrossRef

48.

Offe K, Dodson SE, Shoemaker JT, Fritz JJ, Gearing M, Levey AI, Lah JJ (2006) The lipoprotein receptor LR11 regulates amyloid β production and amyloid precursor protein traffic in endosomal compartments. J Neurosci 26(5):1596–1603PubMedPubMedCentralCrossRef

49.

De Ferrari GV, Inestrosa NC (2000) Wnt signaling function in Alzheimer’s disease. Brain Res Rev 33(1):1–12PubMedCrossRef

50.

Bänziger C, Soldini D, Schütt C, Zipperlen P, Hausmann G, Basler K (2006) Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells. Cell 125(3):509–522PubMedCrossRef

51.

Lorenowicz MJ, Korswagen HC (2009) Sailing with the Wnt: charting the Wnt processing and secretion route. Exp Cell Res 315(16):2683–2689PubMedCrossRef

52.

Belenkaya TY, Wu Y, Tang X, Zhou B, Cheng L, Sharma YV, Yan D, Selva EM, Lin X (2008) The retromer complex influences Wnt secretion by recycling wntless from endosomes to the trans-Golgi network. Dev Cell 14(1):120–131PubMedCrossRef

53.

Harterink M, Port F, Lorenowicz MJ, McGough IJ, Silhankova M, Betist MC, van Weering JR, van Heesbeen RG, Middelkoop TC, Basler K (2011) A SNX3-dependent retromer pathway mediates retrograde transport of the Wnt sorting receptor Wntless and is required for Wnt secretion. Nat Cell Biol 13(8):914–923PubMedPubMedCentralCrossRef

54.

Maurice MM, Korswagen HC (2014) Wnt Signaling in development and disease: molecular mechanisms and biological functions. In: Hoppler SP, Moon RT (eds) Wnt Signal Production, Secretion, and Diffusion. Wiley, New York, pp 3–14

55.

Franch-Marro X, Wendler F, Guidato S, Griffith J, Baena-Lopez A, Itasaki N, Maurice MM, Vincent J-P (2008) Wingless secretion requires endosome-to-Golgi retrieval of Wntless/Evi/Sprinter by the retromer complex. Nat Cell Biol 10(2):170–177PubMedCrossRef

56.

Jackson GR, Wiedau-Pazos M, Sang T-K, Wagle N, Brown CA, Massachi S, Geschwind DH (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34(4):509–519PubMedCrossRef

57.

Clevers H, Nusse R (2012) Wnt/beta-catenin signaling and disease. Cell 149(6):1192–1205. doi:10.1016/j.cell.2012.05.012 PubMedCrossRef

58.

Boonen RA, van Tijn P, Zivkovic D (2009) Wnt signaling in Alzheimer’s disease: up or down, that is the question. Ageing Res Rev 8(2):71–82PubMedCrossRef

59.

Li HL, Wang HH, Liu SJ, Deng YQ, Zhang YJ, Tian Q, Wang XC, Chen XQ, Yang Y, Zhang JY, Wang Q, Xu H, Liao FF, Wang JZ (2007) Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer’s neurodegeneration. Proc Natl Acad Sci USA 104(9):3591–3596. doi:10.1073/pnas.0609303104 PubMedPubMedCentralCrossRef

60.

Caricasole A, Copani A, Caruso A, Caraci F, Iacovelli L, Sortino MA, Terstappen GC, Nicoletti F (2003) The Wnt pathway, cell-cycle activation and β-amyloid: novel therapeutic strategies in Alzheimer’s disease? Trends Pharmacol Sci 24(5):233–238PubMedCrossRef

61.

Almeida CG, Tampellini D, Takahashi RH, Greengard P, Lin MT, Snyder EM, Gouras GK (2005) Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol Dis 20(2):187–198. doi:10.1016/j.nbd.2005.02.008 PubMedCrossRef

62.

Choy RW-Y, Park M, Temkin P, Herring BE, Marley A, Nicoll RA, von Zastrow M (2014) Retromer mediates a discrete route of local membrane delivery to dendrites. Neuron 82(1):55–62PubMedPubMedCentralCrossRef

63.

Zhang D, Isack NR, Glodowski DR, Liu J, Chen CC-H, Xu XS, Grant BD, Rongo C (2012) RAB-6.2 and the retromer regulate glutamate receptor recycling through a retrograde pathway. J Cell Biol 196(1):85–101PubMedPubMedCentralCrossRef

64.

Munsie L, Milnerwood A, Seibler P, Beccano-Kelly D, Tatarnikov I, Khinda J, Volta M, Kadgien C, Cao L, Tapia L (2014) Retromer-dependent neurotransmitter receptor trafficking to synapses is altered by the Parkinson’s disease VPS35 mutation p. D620N. Hum Mol Genet:ddu582

65.

Nakanishi S (1994) Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity. Neuron 13(5):1031–1037PubMedCrossRef

66.

Malinow R, Malenka RC (2002) AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 25(1):103–126PubMedCrossRef

67.

Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE (2004) Synaptic targeting by Alzheimer’s-related amyloid β oligomers. J Neurosci 24(45):10191–10200PubMedCrossRef

68.

Lane RF, St George-Hyslop P, Hempstead BL, Small SA, Strittmatter SM, Gandy S (2012) Vps10 family proteins and the retromer complex in aging-related neurodegeneration and diabetes. J Neurosci 32(41):14080–14086PubMedPubMedCentralCrossRef

69.

Chen Y, Durakoglugil MS, Xian X, Herz J (2010) ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling. Proc Natl Acad Sci 107(26):12011–12016PubMedPubMedCentralCrossRef

70.

Weeber EJ, Beffert U, Jones C, Christian JM, Förster E, Sweatt JD, Herz J (2002) Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J Biol Chem 277(42):39944–39952PubMedCrossRef

71.

Vardarajan BN, Bruesegem SY, Harbour ME, Inzelberg R, Friedland R, St George-Hyslop P, Seaman MN, Farrer LA (2012) Identification of Alzheimer disease-associated variants in genes that regulate retromer function. Neurobiol Aging 33(9):2231 e2215–2231 e2230. doi:10.1016/j.neurobiolaging.2012.04.020 CrossRef

72.

Lucin KM, O’Brien CE, Bieri G, Czirr E, Mosher KI, Abbey RJ, Mastroeni DF, Rogers J, Spencer B, Masliah E, Wyss-Coray T (2013) Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer’s disease. Neuron 79(5):873–886. doi:10.1016/j.neuron.2013.06.046 PubMedPubMedCentralCrossRef

73.

Muhammad A, Flores I, Zhang H, Yu R, Staniszewski A, Planel E, Herman M, Ho L, Kreber R, Honig LS, Ganetzky B, Duff K, Arancio O, Small SA (2008) Retromer deficiency observed in Alzheimer’s disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation. Proc Natl Acad Sci USA 105(20):7327–7332. doi:10.1073/pnas.0802545105 PubMedPubMedCentralCrossRef

74.

Small SA, Petsko GA (2015) Retromer in Alzheimer disease, Parkinson disease and other neurological disorders. Nat Rev Neurosci 16(3):126–132. doi:10.1038/nrn3896 PubMedCrossRef

75.

Mecozzi VJ, Berman DE, Simoes S, Vetanovetz C, Awal MR, Patel VM, Schneider RT, Petsko GA, Ringe D, Small SA (2014) Pharmacological chaperones stabilize retromer to limit APP processing. Nat Chem Biol 10(6):443–449. doi:10.1038/nchembio.1508 PubMedPubMedCentralCrossRef

Title: Cargo trafficking in Alzheimer’s disease: the possible role of retromer
Authors: Saeed Sadigh-Eteghad
Mohammad Sadegh Askari-Nejad
Javad Mahmoudi
Alireza Majdi
Publication date: 01-01-2016
Publisher: Springer Milan
Published in: Neurological Sciences / Issue 1/2016
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-015-2399-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cargo trafficking in Alzheimer’s disease: the possible role of retromer

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2016

Gene expression profiling predicts pathways and genes associated with Parkinson’s disease

Diagnostic delay and prognosis in primary central nervous system lymphoma compared with glioblastoma multiforme

On-period unified Parkinson’s disease rating scale before surgery correlates with differences in outcomes between pallidal and subthalamic stimulation: a meta-analysis

Chiasmal optic neuritis may be secondary to pneumococcal meningitis: a child with acute monocular vision loss

Choroidal thickness measurements in migraine patients during attack-free period

Cerebral insulin, insulin signaling pathway, and brain angiogenesis